Biotech IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024 July 6, 2024
Biotech Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia July 5, 2024
Biotech Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada July 5, 2024
Biotech Specialty Enzymes Market worth $9.2 billion by 2029 – Exclusive Report by MarketsandMarkets™ July 3, 2024
Search
Biotech
July 6, 2024
July 6, 2024
July 6, 2024
July 5, 2024
July 5, 2024
July 5, 2024
July 4, 2024
July 4, 2024
July 4, 2024
July 3, 2024
